SCWorx Corp. Receives Notice from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended March 31, 2024

Stock Information for Reviva Pharmaceuticals Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Reviva Pharmaceuticals Holdings Inc.

SCWorx Reminds Stockholders of Annual Meeting
SCWorx Announces Completion of Equity Financing with Institutional Investors
SCWorx Corp. Receives Notice of Non-Compliance from NASDAQ Stock Market Pertaining to its 10-Q for the quarter ended June 30, 2024
SCWorx Corp. Receives Expected Notice from NASDAQ Stock Market Pertaining to its 10-K of December 31, 2023
SCWorx Signs Letter of Intent to Acquire an Environmental Services Company
SCWorx Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting
New York Hospital Selects SCWorx for Data Management and Workday Implementation Assistance
SCWorx Announces New Hospital Customer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.